C

CareDx
D

CDNA

21.260
USD
0.60
(2.90%)
مفتوح الان
حجم التداول
11,724
الربح لكل سهم
-1
العائد الربحي
-
P/E
-8
حجم السوق
1,141,328,775
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACU
    -0.440
    (-1.17%)
    37.300 USD
    B
    BCRX
    0.06000
    (0.79%)
    7.63000 USD
    C
    CGA
    0.12000
    (6.78%)
    1.89000 USD
    C
    CMP
    -0.060
    (-0.56%)
    10.570 USD
    C
    CRIS
    0.15000
    (4.84%)
    3.25000 USD
    C
    CTIC
    0.11000
    (2.54%)
    4.44000 USD
    NTR
    NTR
    -0.400
    (-0.90%)
    44.190 USD
    المزيد
الأخبار
المقالات

العنوان: CareDx

القطاع: Healthcare
الصناعة: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.